(June 24, 2020) Published this month in the International Journal of Cancer, researchers in Australia have found that “A healthy lifestyle after diagnosis, in particular not smoking and being physically active, may help women with ovarian cancer improve their prognosis.” Over 500 women participated in the study, self-reporting smoking status, height, weight, physical activity, diet … Continued
Recently we announced that OCRA’s 2020 National Conference will take place virtually on September 29-October 2, 2020. We are very excited to bring you an amazing program featuring information on the latest ovarian cancer research and treatment, engaging breakout sessions, self-care and wellness support, and community-building activities, along with a few surprises too! We understand … Continued
Duygu Ozmadenci, PhD, grew up in a small town on the Black Sea region of Turkey, across the waters from Chernobyl. As a teenager, she read a book that told stories of generations of people living in Anatolia and the land that eventually became Turkey. The depictions of the geography and flora, the description of … Continued
(June 11, 2020) Letters of Intent (LOIs) for Ovarian Cancer Research Alliance’s 2021 scientific grant awards are now open for submission. LOIs are due by July 10, 2020. Accepting LOIs is step one of OCRA’s highly competitive grant process. After LOIs are received, they are reviewed by our Scientific Advisory Committee (SAC), an esteemed group … Continued
First-of-its-kind clinical trial validates remote genetic counseling (New York) June 01, 2020 – Genetic testing for cancer risk can significantly improve the prevention or treatment of hereditary cancers, but studies have shown that people who might have a genetic risk often don’t get tested. A collaborative Stand Up To Cancer ‘Dream Team’ of researchers co-funded … Continued
Scared. Overwhelmed. Exhausted. Befuddled. These are common words one might use to describe how we feel during this unprecedented time in history. But Dmitriy Zamarin, MD, PhD, adds “fascinated” to the list as he ponders the psychological and sociological implications of the Covid-19 pandemic. “This small amount of genetic material that has spread through the … Continued
(May 4, 2020) On April 29th, the Food and Drug Administration approved niraparib (Zejula, GlaxoSmithKline) as a first-line maintenance treatment for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer, regardless of BRCA mutation status. Niraparib was first approved by the FDA for treatment of recurrent ovarian cancer in 2017. This most recent approval means … Continued
(April 17, 2020) The Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer brings together women’s healthcare professionals from across the globe to discuss the latest findings in gynecologic oncology. This year, the conference is being held virtually, through a series of high-level webinars that are free and open to the public. Click through to register … Continued
(April 15) The novel coronavirus, COVID-19, has become nearly all consuming. It’s impossible to turn on the news, browse social media, or walk outside without being reminded of the new, albeit temporary, state of the world. In an effort to control, slow, and hopefully stop the spread of COVID-19, drastic public health measures have been … Continued
There are many adjectives one can use to describe ovarian cancer: relentless, cruel, a monster. But Dr. Sunila Pradeep also finds it ironic. “Women spend a lot of time and energy for the next generation. They are playing a major role in continuing life on earth. And then when many of them have fulfilled those … Continued
(April 9, 2020) Why do some gynecologic cancer patients participate in clinical trials, while others do not? Clinical trials are fundamental to the discovery of new and better therapies in the fight against ovarian cancer. Understanding and addressing why patients do or not enroll in trials could help remove unnecessary barriers and involve more patients, … Continued
(April 7, 2020) In a study published last week in the oncology Journal of the American Medical Association, breastfeeding was found to be a factor for reduced risk of developing invasive ovarian cancer. Researchers collected information on close to 10,000 women with ovarian cancer, and found that breastfeeding was associated with a “24% lower risk … Continued
Get email updates about research news, action alerts, and ways to join the fight.
